Skip to content

Clinical trials

Bone Diseases, Metabolic trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Country / region: Canada Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20045
20051
20062
20091
20125
20151
20171
20181
20191
20202
20211
20223
20235
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Unknown status5
Active, not recruiting2
Withdrawn1
Suspended1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
University of Waterloo3
Brock University2
McMaster University2
The Hospital for Sick Children2
University of Calgary2
16 Bit Inc.1
AstraZeneca1
CHU de Quebec-Universite Laval1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic34
Osteoporosis20
Osteoporosis, Postmenopausal5
Fractures, Bone4
Musculoskeletal Diseases4
Bone Diseases3
Prostatic Neoplasms3
Bone Resorption2
Crohn Disease2
Diabetes Mellitus2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.